drugset / Trial / NCT02059915

Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions

NCT02059915

Phase 1 Completed 134 enrolled Pain Therapeutics
RandomizedCrossoverOpen-labelBasic science

Summary

To Compare The Bioavailability Of 40 Mg Doses Of Pf-00345439 Modified Formulation K Vs. Original Formulation X Under Fed And Fasting Conditions In Healthy Volunteers

Timeline

Start
2014-04
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 40 mg

Indications

No indication recorded.